Toward a “two-war legion”: renegotiating First World War memory in the British and American legions, 1938-1946 by Garber, A

The impact of disease stage, indicated by number of previous oral antidiabetic agents, on the clinical benefits of liraglutide in the treatment of type 2 diabetes by Garber, A, Matthews, D, Zinman, B, Thomsen, AB, Falahati, A, Guerci, B

Liraglutide achieved greater weight reduction and improved glycaemic control compared with sitagliptin following one-year treatment when both are used in combination with metformin by Matthews, DR, Sesti, G, Pratley, R, Grimmeshave, L, Xu, Y, Garber, A

Liraglutide add-on to metformin improves postprandial glucose control compared with metformin monotherapy in patients with Type 2 diabetes: posthoc analysis of the Liraglutide Effe... by Stephens, J, Fulcher, G, Matthews, DR, Nauck, M, Svendsen, C, Donsmark, M, Garber, A

Liraglutide, a human GLP-1 analogue, significantly improves beta cell function in subjects with type 2 diabetes by Matthews, DR, Marre, M, Le-Thi, T, Zdravkovic, M, Simo, R, Garber, A, Zinman, B

Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a... by Jendle, J, Nauck, M, Matthews, DR, Frid, A, Hermansen, K, Düring, M, Zdravkovic, M, Strauss, B, Garber, A

The reduction of body weight with liraglutide, a once-daily human GLP-I analogue for type 2 diabetes, primarily comes from fat tissue and the fat tissue lost is predominantly visce... by Jendle, J, Nauck, M, Matthews, D, Frid, A, Hermansen, K, During, M, Zdravkovic, M, Strauss, B, Garber, A

Liraglutide, a human GLP-1 analogue, reduces bodyweight in subjects with type 2 diabetes, irrespective of body mass index at baseline by Schmitz, O, Russell-Jones, D, Shaw, J, Brandle, M, Matthews, D, Frid, A, Zdravkovic, M, Garber, A, Zinman, B